Novel composite implant in craniofacial bone reconstruction

Abstract

Bioactive glass (BAG) and polymethyl methacrylate (PMMA) have been used in clinical applications. Antimicrobial BAG has the ability to attach chemically to surrounding bone, but it is not possible to bend, drill or shape BAG during the operation. PMMA has advantages in terms of shaping during the operation, but it does not attach chemically to the bone and is an exothermic material. To increase the usefulness of BAG and PMMA in skull bone defect reconstructions, a new composite implant containing BAG and PMMA in craniofacial reconstructions is presented. Three patients had pre-existing large defects in the calvarial and one in the midface area. An additive manufacturing (AM) model was used preoperatively for treatment planning and custom-made implant production. The trunk of the PMMA implant was coated with BAG granules. Clinical and radiological follow-up was performed postoperatively at 1 week, and 3, 6 and 12 months, and thereafter annually up to 5 years. Computer tomography (CT) and positron emission tomography (PET-CT) were performed at 12 and 24 months postoperatively. Uneventful clinical recovery with good esthetic and functional outcome was seen. CT and PET-CT findings supported good clinical outcome. The BAG–PMMA implant seems to be a promising craniofacial reconstruction alternative. However, more clinical experience is needed.

Introduction

Traditional skull and facial bone reconstructions with hard tissues have a long history with good clinical outcomes [1–3]. However, they have certain disadvantages, e.g., donor site morbidity [4]. The benefits of synthetic materials are not only the avoidance of donor site morbidity and scars, but also shorter hospitalization time, lower expenses and known composition [5]. Metallic implants have been used alone [6] or combined with bone or hydroxyapatite cement in cranial bone reconstructions [7]. Polymethyl methacrylate (PMMA) resin, polyethylene and hydroxyapatite with various formulations have been utilized in cranial bone reconstructions [8, 9]. Although these materials are readily available for immediate application, they all require preparation, adaptation and contouring into the defect and, later on, resistance to traumatic insults is uncertain. Additive manufacturing technology (AM) has been applied to many medical specialties [10–13]. A custom-made skull bone implant can be produced based on the patient’s preoperative AM three-dimensional mode, and this will result in very high accuracy in terms of the form of the skull defect [14].

Composite implant materials

PMMA is one of the most widely used alloplastic materials in surgery [8, 15]. It has the advantages of being relatively well tolerated by soft tissues and of having a density similar to that of the bone, as well as low thermal conductivity. However, in situ use of PMMA, i.e., a resin mixture of polymer powder and monomer, causes an exothermic reaction by free-radical polymerization. In addition, foreign-body reaction with polymethyl methacrylate has been observed [15].

Bioactive glass S53P4 (BAG) particles of the composition SiO₂ 53.0; CaO 20.0; Na₂O 23.0; P₂O₅ 4.0 wt% have been used in various clinical indications [16–18]. Effects of BAG and clinically important bacteria have been studied experimentally [19, 20]. Microbes lost their viability when placed in contact with BAG [19, 20].

BAG is a brittle and rigid material. It is not possible to drill, bend or shape BAG during the reconstruction operation. Preoperative mechanical preparation of brittle BAG for individual implants is difficult because of the risk of microscopic fractures in the BAG implant, probably leading to an unsafe individual implant. PMMA has advantages in terms of shaping during the operation, but it does not attach chemically to the bone and it is an exothermic material. To variegate BAG and PMMA usefulness in skull bone defect reconstructions, a new composite implant containing BAG granules and PMMA is presented.

Materials and methods

Patients

Of four male patients (mean age of 41 years, range 19–66 years), three needed calvarial and one facial bone defect reconstruction (Table 1). The patients were operated in 2005–2006 in the Turku University Hospital Department of Otorhinolaryngology, Head and Neck Surgery. The study plan was reviewed and approved by the Joint Commission on Ethics of Turku University and Turku University Hospital.

Table 1.

Patients, diagnoses, defect sizes, reconstructions and follow-up periods

Patient number	Age in years	Gender	Diagnosis	Total bone defect size (cm2)	Defect size in percentage for each bone	Reconstruction	Follow-up period in years
1	25	Male	Multiple skull bone fractures with bone loss on the right	140	Right frontal bone 80% Right parietal bone 10% Right temporal bone 60%	Cranioplasty on the right	5
2	57	Male	Multiple skull bone fractures with bone loss on the left	81	Left frontal bone 10% Left temporal bone 60% Left occipital bone 8%	Cranioplasty on the left	5
3	19	Male	Left frontobasal and frontoorbit fractures	6	Left orbit floor and medial floor 80%	Left orbit base reconstruction	5
4	66	Male	Skull bone defect on the left frontal and supraorbital area after repeated meningioma operations	52	Left parietal bone 10% Right frontal bone 40%	Cranioplasty and frontal sinus obliteration on the left	5

Implants

The defect in the patient’s skull (Fig. 1) was detected with a preoperative high-resolution three-dimensional CT study. With the help of the AM (Alphaform Ltd, Rusko, Finland), a custom-made implant (Fig. 2) was prepared by hand (Tables 2, 3). The resin matrix of the implant was a powder–liquid system PMMA bone cement (Palacos-R^®, Heraueus Kulzer GmbH, Germany), and the surface of both sides of the implant was covered with exposed particles of BAG 0.5–0.8 mm in size (BonAlive™, BonAlive Biomaterials Ltd., Finland). The implant’s PMMA trunk was perforated with holes 1.5 mm in diameter (Figs. 2, 3) to enhance tissue ingrowth [21, 22] into the implant and body fluid perfusion (Figs. 2, 3). On the upper surface of the implant, a screw fixation rim with a thickness of 1.0 mm was used to insure the correct position of the implant in the calvarial bone defect and to prevent the implant from sinking too deep into contact with the lamina dura (Fig. 3). The implant was polymerized by autopolymerization, followed by finishing of the contour surfaces of the implant. Then, the implant was post-cured at a temperature of 120°C to optimize the degree of PMMA monomer conversion, thus reducing the quantity of residual monomers in the final implant [23, 24]. The implant was sterilized with the gamma sterilization method preoperatively with a 25 kGy irradiation dose and double packed for clinical use (Isotron Nederland, Netherlands).

Fig. 1.

Photograph of a patient after a car accident. Defect (arrow) from left lateral view (patient 2)

Fig. 2.

Additive manufacturing model of a large left calvarial bone defect and a custom-made PMMA and BAG implant before operation (patient 2)

Table 2.

Composition of PMMA and BAG in weight%

Palacos® PMMA bone cement	BonAlive™ 0.5–0.8 mm granules
Methyl methacrylate 83.5%	Silicon dioxide 53%
Silicon dioxide 14.3%	Sodium dioxide 23%
Benzoyl peroxide 1.0%	Calcium oxide 20%
Gentamicin 1.2%	Phosphorus pentoxide 4%

Table 3.

Detailed implant composition and weight

Patient number	Implant components and weight in grams
1	PMMA 86 g BAG 12 g (on both sides of implant) Total weight 98 g
2	PMMA 60 g BAG 8 g (on both sides of implant) Total weight 68 g
3	PMMA 4.5 g BAG 1 g (on lower side of implant) Total weight 5.5 g
4	PMMA 67 g BAG 10 g (on both sides of implant) Total weight 77 g

Each implant was sterilized with gamma sterilization at 25 kGy

Fig. 3.

The outer surfaces of the implants were covered with BAG granules. The PMMA trunk of the implant was perforated with 1.5 mm perforations to enhance tissue growth into the implant. The implant was adjusted to its correct position in the skull (patient 1)

Implantation technique

The defect site was prepared by isolation of the bone margins through underlying dural and overlying soft tissue dissection. The bony walls of the defects were completely removed from soft tissue. The implants were applied to the bone defects, and the correct position of the implant was ensured with screw fixation (Table 1; Figs. 2, 3). Only minor adjustment of the implants was made with a hand piece and burr under physiologic saline irrigation to achieve accurate implant fit into bony defects. An intraoral approach was used in one patient, whose lateral midface fracture in the right side could not be adequately reconstructed in three previous operations (Table 1, Fig. 4).

Fig. 4.

Custom-made BAG and PMMA implant before secondary reconstruction (patient 3)

Follow-up examinations

The results of the clinical examinations and patients’ symptoms were recorded at 1 week, and 1, 3, 6 and 12 months, and thereafter, annually up to 5 years postoperatively (Table 1). Lateral skull X-ray pictures were obtained at each observation point and CT at 12 months. PET-CT from two patients was performed at 24 months postoperatively. Routine hematologic tests including C-reactive protein (CRP) and creatinine were carried out at postoperative controls only in the case of clinical need. In clinical examinations, special attention was paid to a progressive healing process with diminishing postoperative pain, skin wound healing and clinical position of the implant. In CT or skull X-ray studies, special attention was paid to the border between the implant and surrounding bone to detect any deviations of the permanent fit of the implant into the original defect (Fig. 5). In PET-CT with (18)F-fluoride ion marker, signs of activity of new bone formation between the bone defect margin and the implant were examined (Fig. 6).

Fig. 5.

CT picture of implant 2 years after reconstruction. Implant is in the correct position in the skull. Slight new bone formation between implant and surrounding bone is seen (white arrows, patient 1)

Fig. 6.

PET-CT picture of implant 2 years after reconstruction. (18)F-fluoride marker was used. The implant is in the correct position in the skull. Metabolic activity is shown with colors (white arrows). The highest activity is shown with red and yellow, while green shows lower activity. The middle arrow shows activity on the implant’s outer surface (yellow and red areas), while the other two arrows show activity at the border between the implant and bone (yellow and red areas, patient 1)

Results

Although the defects needed large bone reconstructions (Table 1; Figs. 1–4), there was no mortality. After operation, in the early phase of clinical follow-up from 1 week to 3 months, a progressive healing process with diminishing postoperative clinical symptoms and normally progressing skin wound healing was seen. In skull X-ray studies and clinical examinations, the implants were in the original positions (Figs. 2, 3, 5). Thereafter, the postoperative course was uneventful. However, there was no donor site morbidity because the custom-made implants did not need any graft operations. As a complication, one of the skull bone defect patients had epidural hemorrhage immediately after the operation, which needed surgical intervention. Thereafter, the postoperative course was uneventful. The early and the late esthetic and functional outcomes were good in all three calvarial reconstruction patients, and a satisfactory outcome was achieved with orbit reconstruction (Figs. 5, 7). Hematologic tests revealed no abnormal findings throughout the study. At 2 years postoperatively, both CT and PET-CT studies were performed. In CT studies, the implants were in the original position and an impression of new bone formation was seen (Fig. 5). PET-CT showed activity [25, 26] similar to that reported before with bone healing (Fig. 6).

Fig. 7.

Patient, 2 years after reconstruction (patient 2). Good functional and esthetic outcome is seen

Discussion

Reconstruction of a large skull bone defect is one of the most demanding challenges for surgeons. The gold standard with long clinical experience in bone reconstruction is the use of autogenic bone [1]. However, this method has a disadvantage, namely, donor site morbidity [4] and sometimes enough autogenic tissue for large bone reconstructions or new operations is not available. In this study, three large skull bone defect reconstructions and one orbit reconstruction with a new implant containing BAG and PMMA are presented. AM technologies were utilized in both preoperative planning and in custom-made implant manufacturing. The patients were followed up for up to 5 years. In the present series, there were no long-term complications such as implant-induced skull resorption, loosening of implant or later infections. The esthetic and functional outcomes were good. The combination of biomaterials and AM can offer novel solutions for difficult skull bone reconstructions.

Exposed BAG particles on the surface of the PMMA implant improves bone formation at the interface of the PMMA implant and surrounding bone [27]. In addition, the perforated surface of the implant favors tissue ingrowth of the implant [21, 22]. The bone growth between implant and skull will result in firm adhesion, which in turn may prevent long-term complications. In this study, supposed new bone formation [27] was seen indirectly between an implant and surrounding bone (Figs. 5, 6). These results are similar to those reported before with bone healing [25, 26]. The advantages of the presented composite material are the bioactivity and osteoconductivity of BAG [27], including antimicrobial properties shown in experimental studies [16, 19, 20]. The implants contain no metals related to artefacts in imaging studies, e.g., in CT and MRI [11]. The implant can be fixed with screws or sutures or even set without specific fixation into the calvarial defect under soft tissues. The implant can be shaped with manual and hand-piece instruments. In addition, BAG particles and PMMA can be added to the implant in clinical conditions, when it is necessary to make the implant larger or stronger, e.g., in the case of a larger postoperative defect than estimated in preoperative planning. Donor site morbidity is not related to the custom-made BAG and PMMA composite implant.

In bone reconstruction with biomaterials, the most important practical factors are an adequate knowledge of the biomaterials, their advantages and disadvantages, and the exact composition of the used composite material (Tables 2, 3). Irritation reactions because of exothermic polymerization of PMMA and the presence of free and residual PMMA monomers before and after polymerization [15] can be minimized, when the implant is manufactured in controlled conditions before the operation [23, 24, 28–30]. The total cost of the implant in this study was 2,500 €. However, the shortening of the operating time decreases the total costs of implant reconstruction compared to conventional methods [5, 7, 12]. In the future, the new industrial manufacturing methods will probably reduce the price of the implant.

However, a longer clinical follow-up with more patients is needed before final conclusions can be drawn about the presented composite implant.